Perrigo CO PLC 8-K filings
NYSE
PRGO
Perrigo CO PLCPerrigo Company plc has appointed Todd Penegor, former CEO of The Wendy's Company, to its Board of Directors, effective June 21, 2024.
NYSE
PRGO
Perrigo CO PLC8-K: Perrigo Announces Executive Leadership Transition: General Counsel to Step Down, Interim Appointed
Perrigo Company plc announced that its Executive Vice President, General Counsel, and Corporate Secretary, Kyle L. Hanson, will step down from her role, with Todd Kingma appointed as Interim General Counsel.
NYSE
PRGO
Perrigo CO PLCPerrigo's first quarter results were impacted by challenges in the infant formula business, though the company reaffirmed its full-year outlook and saw strong growth in its international segment.
NYSE
PRGO
Perrigo CO PLCPerrigo Company plc has announced the retirement of Svend Andersen, Executive Vice President and President, Consumer Self-Care International, and the appointment of Roberto Khoury as his successor.
NYSE
PRGO
Perrigo CO PLCPerrigo Company plc held its Annual General Meeting on May 2, 2024, where shareholders elected directors and approved several key proposals.
NYSE
PRGO
Perrigo CO PLCPerrigo Company plc has announced a binding offer from Esteve Healthcare, S.L. to acquire its HRA Pharma Rare Diseases business for up to $275 million.
NYSE
PRGO
Perrigo CO PLCPerrigo Company plc announces that independent director Erica L. Mann will retire from the Board at the 2024 annual general meeting.
NYSE
PRGO
Perrigo CO PLCPerrigo announced record net sales for both the fourth quarter and fiscal year 2023, alongside the launch of a new investment and efficiency program called 'Project Energize'.